EpiCept Corporation announced the initiation of two Phase IIb trials with EpiCept NP-1, a topical prescription analgesic cream for the long-term relief from the pain of peripheral neuropathies.
Ads by Google
Drug Clinical Trials
Bio-Optronics announced that the company would be unveiling Clinical Conductor, a new clinical trial management system.
Preliminary results from a large, randomized clinical trial for patients with newly diagnosed multiple myeloma has shown that the use of a low dose of the steroid dexamethasone, in combination with lenalidomide is associated with improved survival when compared to a treatment regimen with lenalidomide and a higher, standard dose of dexamethasone.
Physicians should consider lowering the dose of the steroid dexamethasone when treating patients with multiple myeloma.
Novagali Pharma, an emerging ophthalmic pharmaceutical company specialized in ophthalmology, announces today positive results from the Phase III clinical study of Vekacia in children suffering from Vernal Keratoconjunctivitis.
LigoCyte Pharmaceuticals Inc. announced today that it has initiated the Phase I clinical trial of its investigational Norovirus vaccine at the University of Maryland Medical Center.
NanoBio Corporation, a biopharmaceutical company developing novel products for the treatment and prevention of serious infections, today announced that the Company has begun enrolling patients in its Phase 2 study of NB-002.
Viventia Biotech Inc., a privately held biopharmaceutical company advancing a portfolio of novel antibody products focused on cancer, announced today that it has initiated patient treatment in its open-label Phase II clinical trial for Vicinium, administered using intravesical instillation for the treatment of locally persistent non-invasive bladder cancer.
NanoBio announced that the Company has begun enrolling patients in its Phase 2 study of NB-002. NB-002 is a drug candidate for the topical treatment of onychomycosis, a fungal infection of the fingernail and toenail.
Physicians at Ohio State University Medical Center are participating in a clinical trial seeking to determine whether early, minimally invasive treatment of small abdominal aortic aneurysms provides better outcomes than watchful waiting of the condition.
The University of Michigan Health System will participate in a large-scale national clinical trial to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease.
Clinical trials are necessary for discovery of new treatments and cures.
This drug research brings us one step closer to needle-free injections.
Roche is temporarily suspending recruitment into its Phase II dose-finding study (NH19960) with the investigational drug C.E.R.A. in anaemic patients with advanced non small cell lung cancer receiving chemotherapy.
Results of a Phase IV study of KADIAN (morphine sulfate extended release) Capsules that demonstrate the pharmacokinetics of the long acting opioid are not significantly affected by the consumption of alcohol.
Researchers take cues from viruses to get treatment through body's protective.
Researchers are sufficiently worried by new study results that they are planning clinical trials involving thousands of people to examine the possible link between Parkinson's disease and statins.
There may be hope in the offing for some sufferers of chronic fatigue syndrome with a new therapy being tested by researchers at the Stanford University School of Medicine.
Animal studies are of limited usefulness to human health: comparison of systematic reviews of animal trials with clinical trials.
AKR 501 is a promising member of a new class of agents called, "TPO receptor agonists" that is now in Phase II clinical development.
Final results from a pivotal Phase II trial evaluating Revlimid in patients with an incurable blood cancer known as myelodysplastic syndromes (MDS).
Pfizer Stops All Torcetrapib Clinical Trials in Interest of Patient Safety.
Cell Therapeutics reported today that enrollment on its PIONEER lung cancer clinical trial has been temporarily suspended while the Company awaits follow up data of recently enrolled patients.
New investigational ADHD treatment, lisdexamfetamine dimesylate yielded a 60 percent improvement in the primary rating scale scores for symptoms of ADHD in children aged 6 to 12 years.
Promising results from a clinical trial led by lung cancer specialist have helped in the effort to get a new drug approved by the Food and Drug Administration to fight an advanced form of the disease.
Early clinical trial of a vaccine for pandemic bird flu suggest the vaccine is safe and well tolerated and may prove effective against divergent strains of the disease.
A significantly greater proportion of people with Multiple Sclerosis taking Fampridine SR had a consistent improvement in walking speed compared to people taking placebo.